Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Cyclohexanol | HCID 7966 | — |
| Reactant | HCID 54445650 | HCID 54445650 | — |
| Catalyst | Titanium(IV)ethoxide | HCID 2724286 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 53799209 | HCID 53799209 | — |
Reaction Steps
8 g (20 mmol) of tert.butyl (S)-8-bromo-12,12a-dihydro-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate, 25 g (250 mmol) of cyclohexanol and 1.8 g (8 mmol) of tetraethyl orthotitanate are stirred at 120° overnight, the excess cyclohexanol is removed in a water-jet vacuum and the residue is taken up in chloroform. The solution obtained is stirred for 0.5 hour with 40 ml of a 1:1 mixture of concentrated hydrochloric acid and water, the organic phase is separated, washed once with 1N hydrochloric acid and once with saturated sodium bicarbonate solution, dried over magnesium sulphate and evaporated. By recrystallization from ethanol there is obtained cyclohexyl (S)-8-bromo-12,12a-dihydro-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxylate of melting point 203°-204°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04489003 |
|---|
| Source dataset | uspto-grants-1984_12 |
|---|
| ORD ID | ord-d4fb474457554f4ebe529d80670381e9 |
|---|
| Source note | uspto-grants-1984_12 |
|---|